John Crowley
2022
In 2022, John Crowley earned a total compensation of $1.4M as Chief Financial Officer at Fusion Pharmaceuticals, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $163,146 |
|---|---|
| Option Awards | $772,909 |
| Salary | $458,274 |
| Other | $48,684 |
| Total | $1,443,013 |
Crowley received $772.9K in option awards, accounting for 54% of the total pay in 2022.
Crowley also received $163.1K in non-equity incentive plan, $458.3K in salary and $48.7K in other compensation.
Rankings
In 2022, John Crowley's compensation ranked 2,300th out of 5,683 executives tracked by ExecPay. In other words, Crowley earned more than 59.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,300 out of 5,683 | 60th |
Division Manufacturing | 1,247 out of 3,091 | 60th |
Major group Chemicals And Allied Products | 555 out of 1,406 | 61st |
Industry group Drugs | 510 out of 1,307 | 61st |
Industry Biological Products, Except Diagnostic Substances | 125 out of 295 | 58th |
Source: SEC filing on April 27, 2023.
Crowley's colleagues
We found two more compensation records of executives who worked with John Crowley at Fusion Pharmaceuticals in 2022.